Company Filing History:

8 out of 64

Dynavax Technologies Corporation

patents

New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery

patents

Years Active: 2003-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11197890 - Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines (2021-12-14),

2. 9868955 - Human toll-like receptor inhibitors and methods of use thereof (2018-01-16),

3. 9476053 - Methods and compositions for inhibition of immune responses and autoimmunity (2016-10-25),

4. 9347064 - Methods of treatment using TLR7 and/or TLR9 inhibitors (2016-05-24),

5. 9228184 - Human toll-like receptor inhibitors and methods of use thereof (2016-01-05),

6. 9063123 - Transgenic mice expressing human toll-like receptor 8 (2015-06-23),

7. 8962579 - Methods and compositions for inhibition of immune responses and autoimmunity (2015-02-24),

8. 8940310 - Methods of treatment using TLR7 and/or TLR9 inhibitors (2015-01-27),

9. 8759305 - Methods and compositions for inhibition of innate immune responses and autoimmunity (2014-06-24),

10. 7122340 - Regulatory T cells; methods (2006-10-17),

11. 6670146 - Regulatory T cells; methods (2003-12-30),

Title: Innovator Spotlight: Franck J Barrat - Revolutionizing Disease Treatment

Introduction:

Franck J Barrat is an esteemed inventor based in San Mateo, California, with a remarkable portfolio of 11 patents. His groundbreaking work in the field of treating cancer, infectious diseases, and autoimmune diseases using CXC chemokines has significantly advanced the realm of modern medicine.

Latest Patents:

Among his latest patents, Franck J Barrat has developed innovative methods for treating cancer, infectious diseases, and autoimmune diseases by leveraging the therapeutic potential of CXC chemokines and their associated receptors. These methods have showcased promising results in preventing and combating a wide range of diseases, including cancer, autoimmune disorders, and infectious illnesses.

Career Highlights:

Throughout his career, Franck J Barrat has made significant contributions to the biopharmaceutical industry. He has worked with renowned companies such as Dynavax Technologies Corporation and Schering Corporation, where his expertise and innovative approach have led to groundbreaking developments in disease treatment and prevention.

Collaborations:

Franck J Barrat has collaborated with esteemed professionals in the field, including Cristiana Guiducci and Robert L Coffman. Together, they have synergized their expertise to drive forward novel research initiatives and develop cutting-edge solutions for combating complex diseases.

Conclusion:

In conclusion, Franck J Barrat stands as a visionary inventor whose dedication to advancing medical science has paved the way for groundbreaking innovations in disease treatment and prevention. His pioneering work continues to inspire and shape the future of healthcare, offering hope to individuals battling cancer, autoimmune diseases, and infectious illnesses worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com